Vaccination against the intracellular pathogens Leishmania major and L. amazonensis by directing CD40 ligand to macrophages

Infection and Immunity

Volumn 69, Issue 5, 2001, Pages 3255-3263

  Chen, G ^a   Darrah, P A ^a   Mosser, D M ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 39; INTERLEUKIN 12; PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNOPOTENTIATION; LEISHMANIA; LEISHMANIA MAJOR; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; VACCINATION;

ANIMALS; CD40 LIGAND; FEMALE; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTOZOAN VACCINES; VACCINATION;

EID: 0035060828     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.5.3255-3263.2001     Document Type: Article

References (45)

1. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major
2. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome
3. The CD40 antigen and its ligand
4. Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years
5. Interaction of Leishmania gp63 with cellular receptors for fibronectin
6. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis
7. CD40 ligand and its role in X-linked hyper-IgM syndrome
8. CD40 ligand is required for protective cell-mediated immunity to Leishmania major
9. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice
10. Molecular determinants of Leishmania virulence
11. A common major surface antigen on amastigotes and promastigotes of Leish-mania species
12. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63
13. Progressive disease or protective immunity to Leishmania major infection: The result of a network of stimulatory and inhibitory interactions
14. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb
15. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis
16. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand
17. CD40 ligand/timer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious tumor challenge
18. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice
19. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
20. Induction of IL-I2 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction
21. Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses
22. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes
23. Functions of CD40 and its ligand, gp39 (CD40L)
24. Surface antigens of Leishmania donovani promastigotes
25. Genetic control of the immune response in mice to Leishmania mexicana surface protease
26. Leishmania amazonensis: The phagocytosis of amastigotes by macrophages
27. Analysis of the active site and activation mechanism of the Leishmania surface metal-loproteinase gp63
28. The regulation of IL-12: Its role in infectious, autoimmune, and allergic diseases
29. Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-1 (CD11b/CD18)
30. Expression cloning of a protective Leishmania antigen
31. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anticytokine antibodies
32. The regulation of immunity to Leishmania major
33. Constructing polycompetitor cDNAs for quantitative PCR
34. Leishmania promastigotes evade IL-12 induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection
35. Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells
36. 1L-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis
37. The role of the innate immune response in Th1 cell development following Leishmania major infection
38. IL-12: Initiation cytokine for cell-mediated immunity
39. IL-12 as an adjuvant for cell-mediated immunity
40. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming
41. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection
42. Selective suppression of interleukin-12 induction after macrophage receptor ligation
43. Reversal of proinflammatory responses by ligating the macrophage Fcγ, receptor type I
44. Limiting dilution assays for the determination of immuno-competent cell frequencies. III. Validity tests for the single-hit Poisson model
45. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist